PULSAR in Systemic Therapy for Pancreatic Cancer

Clinical trial NCT07269626 · RECRUITING

Trial details

NCT number: NCT07269626
Sponsor: Samsung Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Ductal Adenocarcinoma Borderline Resectable Pancreatic Ductal Adenocarcinoma Oligometastatic Pancreatic Ductal Adenocarcinoma

Start date: 2025-11-14
Primary completion: 2027-12-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.